COMMUNIQUÉS West-GlobeNewswire
-
Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs
17/06/2026 -
Oncotelic Advances AI-Powered GMP Manufacturing Services Platform for Revenue-Generating AI and Robotics Manufacturing Services
17/06/2026 -
NeOnc's Global Expansion Accelerates After Abu Dhabi IND Approval for NEO212
17/06/2026 -
Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026
17/06/2026 -
Elicio Therapeutics Reports Multiple Complete Responses After ELI-002 7P Treatment and Subsequent Therapy with Checkpoint Inhibition in Metastatic mKRAS Pancreatic Cancer
17/06/2026 -
TOMI Advances Toward NSF Certification to Address Multi-Billion-Dollar Pharmaceutical, Biotech and Cleanroom Decontamination Markets
17/06/2026 -
MedX Holdings Accelerates Growth: Expanding Lazydaze Franchise Footprint, Unveiling Major Product Innovations, and Strengthening Brand Infrastructure
17/06/2026 -
Zelluna ASA: Contemplated Private Placement and Retail Offering to Strengthen its Position Ahead of Initial Clinical Data
17/06/2026 -
Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products
17/06/2026 -
Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis
17/06/2026 -
electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference
17/06/2026 -
Merakris Therapeutics Awarded U.S. Department of Veterans Affairs Federal Supply Schedule Contract, Expanding Federal Market Access for Dermacyte® AC Matrix Amniotic Membrane Allograft
17/06/2026 -
Polyrizon Receives Notice of U.S. Patent Publication for Mucoadhesive Drug Delivery Platform
17/06/2026 -
Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026
17/06/2026 -
SYNAPSE-CMT Phase 2a Clinical Study Data Presented in Late-Breaking Oral Presentation at 2026 PNS Annual Meeting
17/06/2026 -
Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering
17/06/2026 -
Avricore Health Closes $1.254 Million Financing
17/06/2026 -
BrewDog Turns Up Father’s Day Across the U.K. with Gift-Ready Beer, Custom Cans and Dads Eat Free
17/06/2026 -
Step Pharma advances dencatistat into phase 2 clinical trial for essential thrombocythaemia
17/06/2026
Pages